During a recent board meeting of the UK National Institute for Health and Care Excellence (NICE), Chapman provided an update on the EVA scheme, which aims to expedite the use of innovative medical devices for National Health Service (NHS) patients in England.
“The EVA is a catalyst to change the way we think about medical technology assessment as a whole. And if we don't improve those processes and make them faster, then...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?